251
Participants
Start Date
December 31, 2009
Primary Completion Date
January 31, 2011
Study Completion Date
July 31, 2011
Formoterol (OT)
9 μg/dose, Inhaled, twice daily for 52 weeks
Research Site, Nagoya
Research Site, Akita
Research Site, Fukuoka
Research Site, Chitose
Research Site, Obihiro
Research Site, Sapporo
Research Site, Ako
Research Site, Kobe
Research Site, Hitachi
Research Site, Tsukuba
Research Site, Kanazawa
Research Site, Sakaidechō
Research Site, Fujisawa
Research Site, Kawasaki-shi
Research Site, Yokohama
Research Site, Kōshi
Research Site, Kyoto
Research Site, Nagaoka
Research Site, Saiki-shi
Research Site, Moriguchi
Research Site, Matsue
Research Site, Bunkyo
Research Site, Chūō
Research Site, Katsushika-ku
Research Site, Kodaira
Research Site, Setagaya City
Research Site, Tosima-ku
Lead Sponsor
AstraZeneca
INDUSTRY